"Pregnenediones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures.
Descriptor ID |
D011282
|
MeSH Number(s) |
D04.210.500.745.745.654
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pregnenediones".
Below are MeSH descriptors whose meaning is more specific than "Pregnenediones".
This graph shows the total number of publications written about "Pregnenediones" by people in this website by year, and whether "Pregnenediones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pregnenediones" by people in Profiles.
-
Shishodia S, Azu N, Rosenzweig JA, Jackson DA. Guggulsterone for Chemoprevention of Cancer. Curr Pharm Des. 2016; 22(3):294-306.
-
Shishodia S, Sethi G, Ahn KS, Aggarwal BB. Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem Pharmacol. 2007 Jun 30; 74(1):118-30.
-
Shishodia S, Aggarwal BB. Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J Biol Chem. 2004 Nov 05; 279(45):47148-58.